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Abstract 
Evidence has shown that the gastrointestinal microbiome plays an important role in 
response to infectious disease. Porcine reproductive and respiratory syndrome virus (PRRSV) 
and porcine circovirus type 2 (PCV2) are two of the most important pathogens affecting the 
swine industry worldwide. Co-infections are common on a global scale, resulting in pork 
production losses through reducing weight gain and causing respiratory disease in growing pigs. 
Our initial microbiome work demonstrated that the fecal microbiome was associated with 
clinical outcome of pigs 70 days post-infection (dpi). However, it remained uncertain if 
microbiome characteristics could predispose response to viral challenge. The purpose of this 
study was to determine if microbiome characteristics present at the time of viral challenge were 
associated with outcome after co-infection. Using the Lawrence Livermore Microbial Detection 
Array, we profiled the microbiome in feces on 0 dpi from pigs identified as having high or low 
growth rates after co-infection. High growth rate pigs had less severe interstitial pneumonia, 
reduced PRRSV replication, and a significant increase in average daily weight gain throughout 
the study. At the level of the fecal microbiome, high growth rate pigs had increased microbial 
diversity on both a family and species level. Shifts in the microbiome composition of the high 
growth rate pigs included reduced Methanobacteriaceae species, increased Ruminococcaceae 
species, and increased Streptococcaceae species when compared to low growth rate pigs. Our 
results indicate that both microbiome diversity and composition prior to virus exposure may play 
a role in the subsequent response of pigs to PRRSV/PCV2 co-infection. We followed this study 
by investigating the microbiome characteristics that are present after co-infection and the role of 
the microbiome in subclinical infections. Microbiome analysis at 3 and 6 weeks post-infection 
showed no significant difference between high and low growth rate pigs.  
 The results from both exploring the impact that the initial microbiome has on 
outcome as well as examining the trends in the microbiome during the post-infection period 
demonstrate that microbiome pre-infection composition may play a larger role in the outcome of 
subclinical disease in pigs than microbiome composition during viremia or after viral clearance. 
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1. Introduction 
Microbiome research is an emerging field of research relevant to many fields including 
microbiology, human and animal biomedical research, production medicine, as well as virology. 
The term microbiome signifies the “ecological community of commensal, symbiotic, and 
pathogenic microorganisms that literally share our body space” (Lederberg 2001). The 
microbiome both covers the microbes found in the specific space as well as the genes that are 
encoded by these microbes (Baquero and Nombela 2012). In fact, humans are roughly composed 
of greater than 10 times more residential microbes than bodily cells (Savage 1977). There are 
four general sites of microbial colonization in the human body which can be extrapolated to 
mammals which are the mouth, gut, vagina (or genitourinary tract), and skin (Relman 2002).  
In humans and animals, the gastrointestinal microbiome has been shown to affect a 
variety of different human phenotypes. The microbiome has an operational role in processing 
energy from diet as well as maintaining digestive function regulating fat storage, and regulating 
metabolism (Bäckhed et al. 2004, Nieuwdorp et al. 2014). The effects the microbiome has had on 
metabolism has led to studies focusing on the role of microbiome in weight gain and obesity.  In 
humans, it was found that there is an increase in the proportion of Bacteroidetes in obese patients 
consuming a calorie restricted diet which correlated with weight loss (Ley et al. 2006b). In a 
comparison between anorexic patients, obese patients, and patients with a normal BMI, it was 
found that an increase in the Firmicutes and a decrease in Bacteroidetes correlated with the more 
obese patients in the study (Armougom et al. 2009). In contrast, another study found that an 
increase in the proportion of Bacteroidetes was associated with weight gain and obesity while an 
increase in Methanobrevibacter was associated with weight loss (Schwiertz et al. 2010).  
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In addition to affecting phenotype, the microbiome has been shown to play a role in 
understanding clinical presentations and responses of systemic diseases. The gut microbiome has 
been shown to affect the protective mucus layer of the intestinal tract, improving immunity 
against potential pathogens (Nieuwdorp et al. 2014). There have been a multitude of correlations 
between various diseases and microbiome. For example, an increase in the number of 
Clostridium species has been correlated with late-onset autism (Finegold et al. 2002) with some 
children showing reduction in stereotyped behaviors when treated with antibiotics targeting 
Clostridial species (Bolte 1998). Decreased diversity of the gut microbiome has been associated 
with patients afflicted with myalgic encephalomyelitis/chronic fatigue syndrome (Giloteaux et al. 
2016). Patients with type-2 diabetes show an increase in the abundance of species in the 
Enterobacteriaceae family while butyrate-producing bacteria are depleted (Wang and Jia 2016). 
These are just a few of the many correlations between microbiome and clinical disease. Many 
new revelations are presently being uncovered through the study of the microbiome, however, 
the role of the microbiome in a host’s susceptibility to disease as well as the host’s response to 
pathogens remains poorly understood and further research involving this aspect of microbiome 
research is needed. After combing through and understanding the current literature regarding the 
microbiome, we began to explore avenues concerning the microbiome in swine and the role the 
microbiome plays in swine affected with 2 primary porcine pathogens.  
Porcine reproductive and respiratory syndrome virus (PRRSV) and porcine circovirus 
type 2 (PCV2) are globally endemic viruses that affect the swine production. Both viruses are 
common in young, growing animals, and both viruses are implicated in polymicrobial disease 
syndromes, most specifically porcine respiratory disease complex and porcine circovirus 
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associated disease (PCVAD) (Brockmeier, Halbur, and Thacker 2002, Segales 2012, Trible and 
R.R. Rowland 2012).  Furthermore, co-infections with both viruses has the capacity to enhance 
the disease processes, however, most pigs simultaneously affected with both viruses carry 
subclinical infections (Niederwerder, Bawa, Serao, et al. 2015).  
PRRSV is a small, enveloped, single-stranded RNA virus in the family Arteriviridae 
(Benfield, Nelson, Collins, Harris, Goyal, Robison, T. Christianson, et al. 1992). PRRSV has the 
highest rate of mutation for known RNA viruses, allowing it to escape previous immunity to 
heterologous strains (Murtaugh et al. 2010). In addition to its rapid ability to mutate, PRRSV 
causes decreased weight gain and respiratory disease in growing swine resulting in it being the 
most costly disease of swine production worldwide (Chand, Trible, and Rowland 2012a). 
Modified live vaccines are the most common method used to control the spread of PRRSV 
(Renukaradhya et al. 2015). However, vaccines are considered inadequate for disease control. 
PCV2 is a single-stranded DNA virus in the family Circoviridae which is associated with 
PCVAD which involves muscle wasting, enteric disease, and respiratory disease (Segales 2012). 
One of the hallmarks of PCV2 infections is lymphocyte depletion in lymphoid tissues 
(Opriessnig and Langohr 2013). Although co-infections between PCV2 and PRRSV can 
exacerbate clinical disease, the majority of pigs support subclinical infections which still has 
implications involving poor weight gain (Niederwerder, Bawa, Serao, et al. 2015).  
 As mentioned previously, both PRRSV and PCV2 can cause wasting syndromes in young 
swine which can negatively impact pork production on a global level. New methods to both 
detect and characterize endemic and emerging animal diseases as well as their relationship with 
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the microbiome will allow us to understand how to better control polymicrobial diseases such as 
PRRSV and PCV2.  
Pathogen microbial detection arrays are among the technologies that can be implemented 
to detect emerging and foreign animal diseases in addition to diagnostic clinical application. 
These microbial detection arrays are essentially glass or silicon chips with oligonucleotides 
(probes) containing specific DNA sequences attached to their surface. These probes target both 
conserved and unique sequences making these arrays effective in recognizing microbes in 
selected samples. Select samples are prepared and labeled with a fluorescent marker and then 
hybridized to the array chip. RNA viruses can also be recognized in the form of cDNA after 
performing a reverse transcriptase experiment. As of June 2013, the Lawrence Livermore 
Microbial Detection Array (LLMDA), targets all vertebrate infecting microbes including 3,856 
viruses, 3,855 bacteria, 254 archaebacteria, 100 fungi, and 36 protozoa (Jaing et al. 2015a). 
In 2015, Jaing et al. established that pathogen microarrays, in specific, the LLMDA can 
dependably be utilized to detect both PRRSV and PCV2 in swine serum and tonsil samples as 
well as recognize other microbes present in the samples. This has proved pivotal in determining 
both known and unknown pathogens in porcine diagnostic samples. In this thesis, the application 
of the microarray technique in determining known and unknown pathogens in swine is applied to 
fecal samples collected from pigs in the following studies in order to map individual swine 
microbiomes.   
 In 2015, Niederwerder et al. applied the LLNL microarray to evaluate differences in the 
microbiomes of pigs co-infected with PCV2 and PRRSV when comparing animals with best and 
worst clinical outcomes. Ninety-five pigs were challenged with PRRSV and PCV2 and 
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individual animals’ body weights were recorded on -14, -7, 0, 7, 14, 21, 28, 35, 42, 49, 56, 63, 
and 70 days post-infection (dpi). Blood samples were also collected to measure viremia 
throughout the experiment. The 10 best clinical outcome pigs were selected based on having the 
best average daily gain from 0 to 63 dpi with a complete lack of overt clinical signs, while the 10 
worst clinical outcome pigs were selected as having the lowest average daily gain from 0 to 63 
dpi with at least 10 days of moderate to severe clinical disease. Microarray analysis was 
performed on serum, feces, and lung tissue from 70 dpi. E. coli was detected was detected in 
significantly greater proportion in best outcome pigs compared to worst outcome pigs, indicating 
there may be important differences in microbiome. No significant differences in microbiome 
were detected in the lung tissue. Increased fecal microbiome diversity was recognized with 
improved outcome. This paper by Niederwerder et al. and the paper by Jaing et al. provided the 
foundation of the research highlighted in this thesis.  
Based on these two initial papers, two major objectives were outlined. The first objective 
was to determine what pre-infection microbiome characteristics predispose outcome in 
subclinical infections as well as to determine the role of the microbiome in subclinical infections. 
The second objection was to determine if these changes in the microbiome prior to viral 
challenge are consistent during the post-infection period.  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2. Increased microbiome diversity at the time of infection is 
associated with improved growth rates of pigs after co-infection 
with porcine reproductive and respiratory syndrome virus 
(PRRSV) and porcine circovirus type 2 (PCV2) 
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Introduction 
Pork is the most widely consumed protein around the world and global pork production is 
forecast to reach a record of 111 million tons in 2017 (USDA 2016).  Worldwide, porcine 
reproductive and respiratory syndrome virus (PRRSV) and porcine circovirus type 2 (PCV2) are 
two of the most significant pathogens affecting the swine industry, costing billions in lost 
production over the last 3 decades.  PRRSV is a single-stranded RNA virus in the family 
Arteriviridae (Benfield, Nelson, Collins, Harris, Goyal, Robison, Christianson, et al. 1992) 
which causes reductions in weight gain and respiratory disease in growing pigs.  It is currently 
considered the most costly disease of swine production worldwide (Chand, Trible, and Rowland 
2012a).  PCV2 is a single-stranded DNA virus in the family Circoviridae and is associated with a 
group of disease syndromes termed porcine circovirus associated disease (PCVAD), which 
includes muscle wasting, respiratory disease, and enteric disease (Segales 2012).  Both viruses 
result in systemic infections, cause primary lung pathology, and modulate the immune response.  
For example, PRRSV suppresses innate immunity through antagonizing type I interferon 
production (Chen et al. 2010, Han and Yoo 2014) and PCV2 depletes lymphocytes in lymphoid 
tissues (Opriessnig and Langohr 2013).  Co-infection with the two viruses enhance disease when 
compared to single infections alone and can result in a wide range of overt clinical signs; 
however, overall morbidity is typically less than 30% (Niederwerder, Bawa, Serao, et al. 2015), 
leaving the majority of pigs to support subclinical infections.   
 Playing an essential role in both nutrient availability and immunity (Honda and 
Littman 2016, Turnbaugh et al. 2006), the microbiome, or collection of microorganisms within 
the gastrointestinal tract, has been associated with outcome during systemic viral infections in 
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both humans and mouse models.  Microbiome associations have been found with viruses 
primarily affecting the respiratory tract, such as respiratory syncytial virus and influenza virus 
(Fujimura et al. 2014, Ichinohe et al. 2011), as well as viruses considered immunomodulatory, 
such as human immunodeficiency virus (Mudd and Brenchley 2016).  Disease progression, 
airway inflammation, immune response, and morbidity can all have associations with 
microbiome composition and diversity during these viral infections.  
The role of the microbiome and its impact on the response to systemic infections in swine 
is an emerging area of study and the focus of our work.  To investigate the porcine microbiome, 
we utilized the Lawrence Livermore Microbial Detection Array (LLMDA), which was developed 
to detect all known microbes for which whole genome sequences are available.  Current as of 
June 2013, this technology allows for the detection of 8,101 microbes.  The LLMDA has been 
used in the detection of known and unknown microbes in various porcine samples, including 
feces, serum, lung, oral fluids, lymph node suspension and tonsil (Niederwerder et al. 2016a, 
Jaing et al. 2015a). 
In a recent study, we investigated the associations between the microbiome and clinical 
outcome in pigs following PRRSV/PCV2 co-infection (Niederwerder et al. 2016a).  Best and 
worst clinical outcome pigs were selected based on the presence and severity of clinical disease 
as well as weight gain after co-infection.  The fecal microbiomes of best clinical outcome pigs 
were characterized by increased diversity and increased prevalence of Escherichia coli 70 days 
after co-infection.  While this initial study confirmed a potential role for the microbiome in 
outcome following PRRSV/PCV2 co-infection, important gaps in our knowledge remained, such 
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as microbiome characteristics that predispose outcome and the role of the microbiome in 
subclinical infections.  
 In the current study, we investigated the early microbiome properties that 
predispose high and low growth rates after co-infection in subclinically affected pigs. Our results 
demonstrate that both microbiome diversity and composition prior to infection play a role in 
weight gain following PRRSV/PCV2 co-infection.  
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Materials and Methods 
Animals and housing: All use and experimentation incorporating animals and viruses were 
done in accordance with the Federation of Animal Science Societies (FASS) Guide for the Care 
and Use of Agricultural Animals in Research and Teaching, the USDA Animal Welfare Act and 
Animal Welfare Regulations, and approved by the Kansas State University Institutional Animal 
Care and Use Committees and Institutional Biosafety Committees.  This study was conducted as 
part of a project to evaluate the role of host genetics in determining the outcome following co-
infection with PRRSV and PCV2; a subset of pigs from this project were included in the current 
study.  Three week old barrows (n = 50; average age 23.5 ± 2.6 days) were obtained at weaning 
from a high health commercial herd negative for PRRSV.  While the pigs were derived from a 
sow herd previously vaccinated with a PCV2 capsid subunit vaccine, the piglets were not 
vaccinated for PCV2 and were utilized without regards to maternal antibody.  All pigs were 
housed in a single environmentally controlled room at the Kansas State University Large Animal 
Research Center under BSL-2 conditions.  The piglets were randomly distributed and housed in 
groups of 8-10 pigs per 13.4 m2 pen.  All pigs were given a period of approximately 4 weeks to 
acclimate to their new environment prior to co-infection.  Pigs were given access to food and 
water ad libitum.  
Viruses: The PRRSV and PCV2b viral isolates used to prepare the inoculum for this study were 
originally derived from the lymph node of a pig with severe postweaning multisystemic wasting 
syndrome (PMWS) as previously described (Trible et al. 2012).  PRRSV (isolate KS62; 
GenBank accession no. KM035803) was isolated by propagation on MARC-145 cells.  Since 
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wild-type PCV2b (GenBank accession no. JQ692110) does not propagate to high levels in cell 
culture, we took advantage of the heat stability of the virus to prepare a lymph node suspension 
enriched for PCV2 as previously described (Niederwerder et al. 2016a, Niederwerder, Bawa, 
Serao, et al. 2015).  The isolated PRRSV was recombined with the heat-treated PCV2 
homogenate to co-infect cesarean-derived, colostrum-deprived (CD/CD) pigs.  A combination 
lung/lymph node homogenate was prepared from the CD/CD pigs, and PRRSV and PCV2 were 
isolated from the homogenate by the methods described.  Analysis of the inoculum yielded 
negative results for most heat-stable agents, but was positive for two viruses ubiquitous to swine, 
including Torque teno sus virus (TTSuV) and porcine endogenous retrovirus (PERVs) (Jaing et 
al. 2015a). 
PCV2b was titrated on swine testicle (ST) cells.  Briefly, serial 10-fold dilutions of PCV2 
challenge stock were plated in quadruplicate onto rapidly dividing ST cells in a 96-well tissue 
culture plate (BD Falcon).  Dilutions were prepared in Eagle’s minimal essential medium 
(EMEM; Sigma-Aldrich) supplemented with 7% fetal bovine serum (FBS; Sigma-Aldrich) and 
50 µg/mL of gentamicin (Lonza).  Following a 3-day incubation at 37˚C in 5% CO2, cells were 
fixed and permeabilized with 80% acetone.  Cells were then stained with fluorescein 
isothiocyanate (FITC)-labeled porcine anti-PCV (Veterinary Medical Research and 
Development, Inc.).  Infected cells were visualized using an inverted fluorescent microscope and 
the 50% tissue culture infectious dose (TCID50/mL) was calculated using the method of Reed 
and Muench (Reed and Muench 1938).  
MARC-145 cells were used for the titration of PRRSV.  Briefly, virus was serially diluted 
1:10 in minimal essential medium (MEM; Corning) supplemented with 7% FBS (Sigma-
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Aldrich), penicillin-streptomycin (Pen Strep; 80 Units/mL and 80 µg/mL, respectively; Gibco), 3 
µg/mL amphotericin B (Fungizone; Gibco), and 25 mM HEPES (Life Technologies).  The 
dilutions were then added in quadruplicate to confluent MARC-145 cells in a 96-well tissue 
culture plate (BD Falcon).  Following a 4-day incubation at 37˚C in 5% CO2, cells were 
examined for PRRSV-induced cytopathic effects.  The TCID50/mL was calculated using the 
method of Reed and Muench (Reed and Muench 1938).  
Experimental design and sample collection: At approximately 8 weeks of age (average age 
54.5 ± 2.6 days), all 50 pigs were infected with PRRSV and PCV2b.  The viruses were 
recombined to yield a 2-mL dose consisting of 103.6 TCID50 PCV2b and 105 TCID50 PRRSV in 
MEM.  The 2-mL dose was split, with 1 mL being delivered intranasally and 1 mL being 
delivered intramuscularly.  Body weights of individual pigs were collected upon arrival and on 0, 
7, 14, 21, 28, 35, and 42 days post-infection (dpi).  Blood samples were collected from all pigs 
on 0, 4, 7, 11, 14, 21, 28, 35, and 42 dpi.  Fecal samples were collected from all 50 pigs during 
the week prior to co-infection.  At 35 dpi, 20 pigs were selected to represent high growth rate 
pigs (n = 10) and low growth rate pigs (n = 10).  To select these two groups, the average daily 
gain (ADG) was calculated between 0 and 35 dpi as the change in weight over the change in time 
and reported in kg.  Pigs in the high growth rate group had the highest ADG and pigs in the low 
growth rate group had the lowest ADG.  The two groups were balanced according to initial 
weight on 0 dpi.  Any pig that had overt clinical disease requiring veterinary medical treatment 
(as described below) was excluded from selection.  At 42 dpi, all 20 pigs were humanely 
!12
euthanized in accordance with the American Veterinary Medical Association Guidelines for the 
Euthanasia of Animals and complete necropsies were performed.  
Clinical and pathologic evaluation: All pigs were assessed daily for the presence of clinical 
signs associated with PRRSV/PCV2 co-infection, such as dyspnea, coughing, nasal discharge, 
aural cyanosis, open mouth breathing, decreased body condition, muscle wasting, lethargy, 
depression, joint effusion, lameness, and pallor or jaundice.  Pigs were visually examined by a 
veterinarian or veterinary assistant on each day of the study period.  Under the direction of a 
veterinarian, appropriate treatments were administered to pigs with moderate to severe clinical 
disease.  Examples of clinical presentations where treatment was administered included 1) 
dyspnea, 2) mucoid rhinorrhea, 3) lameness with joint effusion, 4) pallor or jaundice with muscle 
wasting, and 5) lethargy or depression with pyrexia.  Clinically affected pigs were administered 
parenteral antibiotics, such as ceftiofur hydrochloride, oxytetracycline, or enrofloxacin.  Any pig 
with overt clinical disease and a rectal temperature of ≥ 104˚F was administered parenteral 
flunixin meglumine, a nonsteroidal anti-inflammatory drug.  For those pigs with pyrexia lasting 
longer than 4 days, a 2 day wash-out period was prescribed prior to the administration of oral 
meloxicam.  Any pig with documented clinical disease requiring veterinary medical treatment 
was excluded from the high and low growth rate groups for this study.    
At 42 dpi, all pigs were humanely euthanized with intravenous pentobarbital sodium.  A 
board certified veterinary pathologist, blinded to the source of the pigs, performed complete 
necropsies and histopathology.  Tissues collected included lung (1 section from each lobe) and 
tracheobronchial lymph node.  Tissues were fixed in 10% neutral buffered formalin for at least 7 
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days, routinely processed in an automated tissue processor, embedded in paraffin, and stained 
with hematoxylin and eosin (H&E stain).  Microscopic lung lesions were scored using a 0-4 
system as previously described (Niederwerder et al. 2016a, Niederwerder, Bawa, Serao, et al. 
2015).  Scores were assigned as follows: 0, no significant lung lesions; 1, mild multifocal 
interstitial pneumonia with <50% lung lobe involvement; 2, mild to moderate multifocal 
interstitial pneumonia with 50-75% lung lobe involvement; 3, moderate to severe multifocal 
interstitial pneumonia with 50-75% lung lobe involvement; 4, severe diffuse interstitial 
pneumonia with >75% lung lobe involvement.  Degree of lymphoid depletion was scored using a 
0-3 system as previously described (Niederwerder et al. 2016a).  Scores were assigned as 
follows: 0, no lymphoid depletion; 1, mild or small amount of lymphoid depletion; 2, moderate 
or intermediate amount of lymphoid depletion; 3, severe or large extent of lymphoid depletion.   
Measurement of PRRSV and PCV2 viremia: Viral DNA and RNA was extracted 
simultaneously from 50 µL of serum using Ambion’s MagMAX 96 Viral Isolation Kit (Applied 
Biosystems) in accordance with the manufacturer’s instructions.  PRRS viral RNA was 
quantified using EZ-PRRSV MPX 4.0 Real Time RT-PCR Target-Specific Reagents (Tetracore) 
according to the manufacturer’s instructions.  For consistency, each plate contained Tetracore 
Quantification Standards and Control Sets for use with EZ-PRRSV MPX 4.0 RT-PCR Reagents.  
All PCR reactions were carried out on a CFX96 Touch Real-Time PCR Detection System (Bio-
Rad) in a 96-well format using the recommended cycling parameters.  The PCR assay results 
were reported as log10 PRRSV RNA starting quantity (copy number) per 50 µL reaction volume. 
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PCV2 DNA was quantified using SsoAdvanced Universal SYBR green supermix (Bio-
Rad) as previously described (Niederwerder, Bawa, Serao, et al. 2015, Niederwerder et al. 
2016a).  Briefly, forward and reverse PCR primers were 5’-AATGCAGAGGCGTGATTGGA-3’ 
and 5’-CCAGTATGTGGTTTCCGGGT-3’, respectively, and were used at a final concentration 
of 300 µM.  Standard curves and positive and negative controls were included on each plate.  
Plasmid DNA was used for the PCV2 standard curve and positive control template.  DNA 
inserted into the plasmid was obtained from a field strain of PCV2 (PCV2b 321/393).  The PCV2 
PCR was carried out on a CFX96 Touch Real-Time PCR Detection System using the following 
settings: activation at 98°C for 2 minutes, followed by 40 cycles of denaturing at 98°C for 5 
seconds and annealing/extension at 60°C for 10 seconds.  The PCR assay results were reported 
as log10 PCV2 DNA starting quantity (copy number) per 20 µL reaction volume. 
Microarray Analysis of Fecal Samples: The Lawrence Livermore Microbial Detection Array 
(LLMDA) developed at the Lawrence Livermore National Laboratory was designed to detect all 
sequenced microbes.  The version 7 of the LLMDA in the 4plex 180K probe format was used to 
analyze the microbiome in fecal samples from this study.  This version of the array targets all 
vertebrate infecting microbes including 3,856 viruses, 3,855 bacteria, 254 archaebacteria, 100 
fungi, and 36 protozoa.  The LLMDA oligonucleotide probes are around 60 nucleotides in length 
and were designed to detect all sequenced microbial families with a large number of probes per 
sequence (average of 30 probes) to improve sensitivity in the evaluation of microbial nucleic 
acids in a variety of samples.  The high-density oligo LLMDA microarray and statistical analysis 
method have been extensively tested in numerous studies for viral and bacterial detection in pure 
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or complex environmental and clinical samples (Jaing et al. 2015a, Gardner et al. 2010a, 
Rosenstierne et al. 2014a, Niederwerder et al. 2016a).  
DNA and RNA from fecal samples were extracted using the PowerViral™ Environmental 
RNA/DNA Isolation Kit (MO BIO, San Diego, CA) in accordance to the manufacturer’s 
instructions.  Briefly, for each sample approximately 0.25 g of feces was added to 600 µl of PV1 
in a bead beating tube included in the PowerViral™ kit.  Samples were homogenized and lysed 
using the vortex adaptor for the MO BIO Vortex-Genie 2 for 10 minutes at maximum speed.  
Samples were further purified using the manufacturer’s standard protocols.  All samples were 
eluted into 100 µl of RNase-Free water.  The purified nucleic acids were quantified using the 
Life Technologies Qubit fluorimeter.  For each sample, 10 µl of the extracted DNA and RNA was 
amplified using the random amplification procedure as previously described (Rosenstierne et al. 
2014a).  The amplified cDNA and DNA was purified with the Qiaquick PCR purification 
columns (Qiagen) and quantified using the Qubit fluorometer.  Between 400-500 ng of amplified 
cDNA and DNA were fluorescently labeled using a one-coloring labeling kit (Roche NimbleGen, 
Madison, WI) following the manufacturer’s instructions. 
Comparative genomic hybridization (CGH) mix was prepared in the following manner 
using the Agilent Technologies Oligo aCGH/ChIP-on-Chip Hybridization kit (Santa Clara, CA).  
For each sample, 10 µg of fluorescently labeled DNA was mixed with CGH mastermix, 
denatured at 95˚C for 3 min, and incubated at 65˚C until the arrays were ready to load.  The 
LLMDA version 7 4x180K format microarray (Agilent Technologies Inc., Santa Clara, CA) was 
utilized for this experiment.  Each sample was loaded onto the array and hybridized for 40 hr at 
65˚C in a microarray rotator oven (Agilent Technologies Inc., Santa Clara, CA) set to a speed of 
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20.  Microarrays were then washed using the standard manufacturer’s protocol with Oligo 
aCGH/ChIP-on-chip Wash Buffer 1 and Oligo aCGH/ChIP-on-chip Wash Buffer 2 (Agilent 
Technologies Inc., Santa Clara, CA).  The arrays were each washed in CGH Wash 1 for 5 min at 
room temperature, followed by CGH Wash 2 for 1 min at 37˚C.  Arrays were then streamed with 
nitrogen gas to remove particulate matter from the surface.  Using the MS200 microarray 
scanner (Roche NimbleGen, Madison, WI), all arrays were scanned at a resolution of 2 µM.  
Microarray data was generated from the microbe sequences at ≥99% threshold using the 
CLiMax method developed at Lawrence Livermore National Laboratory (Gardner et al. 2010a).  
The log likelihood for each of the positive targets is estimated from the BLAST similarity scores 
of the array feature and target sequences, together with the feature sequence complexity and 
other covariates derived from BLAST results. 
Statistical Analysis: All statistical analyses were performed using GraphPad Prism 7.01 
software (La Jolla, CA).  Mean weekly weights, ADG, and viremia were compared between 
groups using the unpaired t-test.  Microscopic lung and lymph node lesion scores were compared 
between groups using the Mann-Whitney U test.  Microbiome diversity and number of species 
within family and phylum were compared between groups using the Mann-Whitney U test.  
Proportions of each growth rate group with individual species and families detected were 
compared using Fisher’s exact test.            
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Results 
Weight gain of high and low growth rate groups diverged after co-infection: Of the 50 pigs, 
10 pigs had moderate to severe clinical disease that required veterinary medical treatment (20% 
overall morbidity).  No mortalities occurred during the 42 dpi.  Thus, 40 pigs qualified for 
selection of the high and low growth rate groups; these pigs supported subclinical infections or 
had mild and transient clinical disease that did not require veterinary intervention or antibiotic 
treatment.  ADG between 0 and 35 dpi was used as the criteria for the selection of the two groups 
of pigs in this study (Fig. 1A).  Mean ADG for the 10 high growth rate pigs was 0.903 ± 0.043 
kg, with a range between 0.836 kg and 0.962 kg.  This compares to a mean ADG for the 10 low 
growth rate pigs of 0.755 ± 0.075 kg, with a range between 0.596 kg and 0.827 kg.  ADG values 
between the two groups did not overlap.  Mean ADG difference between the groups was 
statistically significant (p < 0.0001, unpaired t-test).  Mean weights upon arrival after weaning 
were 5.3 ± 0.6 kg and 5.7 ± 0.9 kg for the low and high growth rate groups, respectively (p = 
0.26, unpaired t-test).  Mean weights continued to be similar during the acclimation period and 
on the day of co-infection; 19.2 ± 2.2 kg for the low growth rate group and 19.5 ± 1.9 kg for the 
high growth rate group on 0 dpi (p = 0.75, unpaired t-test; Fig 1B).  No significant difference 
was detected between the mean weights of the two groups prior to virus infection.   
After infection, the mean weights between the two groups began to diverge, initially 
noting a trend for absolute weight differences on 21 and 28 dpi (see Fig. 1B).  On 21 dpi, mean 
weights for the low and high growth rate groups were 33.1 ± 4.3 kg and 36.1 ± 2.6 kg, 
respectively (p = 0.077, unpaired t-test).  By 28 dpi, mean weights had diverged by 
approximately 4.4 kg; low growth rate pigs weighed an average of 38.7 ± 4.7 kg and high growth 
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rate pigs weighed an average of 43.1 ± 6.1 kg (p = 0.09, unpaired t-test).  It was not until 35 and 
42 dpi that mean weights between the high and low growth rate groups were significantly 
different (p = 0.001 and p = 0.028, respectively).  Final weights on 42 dpi were 52.5 ± 5.3 kg and 
57.1 ± 2.9 kg for the low and high growth rate groups, respectively. 
High growth rate pigs had reduced PRRSV and PCV2 replication: PRRSV and PCV2 
viremia were measured at 9 time points during the course of the study.  Individual days as well as 
total virus replication were compared between the two groups.  Overall, PRRS virus replication 
in the low growth rate group had a more rapid increase and a more prolonged decay (Fig. 1C).  
On 4 dpi, mean viral loads for the low and high growth rate groups were 4.1 and 3.6 log10 copies/
PCR reaction, respectively (p = 0.03, unpaired t-test).  Both groups had peak PRRS virus 
replication on 11 dpi.  On 14 dpi, high growth rate pigs had a significant decline in PRRSV 
viremia; viral loads for low and high growth rate pigs were 4.4 and 2.8 log10 copies/PCR 
reaction, respectively (0.004, unpaired t-test).  A trend for reduced PRRS virus replication in the 
high growth rate pigs continued on 21 dpi (0.05, unpaired t-test). 
 PCV2 viremia followed a similar trend to PRRSV, with low growth rate pigs 
having a more rapid rise in viral load followed by a more gradual decline (Fig. 1D).  Significant 
differences between the two groups were noted on days 11 and 14 post-infection.  On 11 dpi, 
mean PCV2 loads for the low and high growth rate groups were 1.3 and 0.4 log10 copies/PCR 
reaction, respectively (p = 0.03, unpaired t-test).  On 14 dpi, the low growth rate group continued 
to have an increase in mean virus load of approximately 0.73 log10 copies/PCR reaction (p = 
0.019, unpaired t-test).  This trend continued at 21 dpi; however, group differences were not 
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statistically significant (p = 0.086, unpaired t-test).  Overall, virus replication followed a similar 
pattern in the two groups, peaking at 28 dpi and initiating a decay in PCV2 at 35 dpi (Fig. 1D).     
 Total virus replication over the 42-day study was determined by calculating the 
area under the viremia curve (AUC) as previously described (Boddicker et al. 2012, 
Niederwerder et al. 2016a).  The PRRSV AUC ranges for the low and high growth rate groups 
were 83.3-115.6 and 56.0-87.7, respectively, with only a single value overlapping between the 
two groups.  Mean PRRS viral load for the low and high growth rate groups was 98.6 ± 8.5 and 
78.3 ± 9.9, respectively.  This difference was statistically significant (p = 0.0001, unpaired t-test).  
For PCV2, there was significant variation and a broad range of total virus load in each of the 
groups; 0-94.9 and 0-77.5 for the low and high growth rate pigs, respectively.  Mean PCV2 AUC 
values were higher in low growth rate pigs; 57.6 ± 28.5 and 35.6 ± 22.6 for the low and high 
growth rate groups, respectively.  However, this difference was not statistically significant (p = 
0.07, unpaired t-test).  Taken together, this data further supports the role for pathogen load in 
determining the outcome after PRRSV/PCV2 co-infection.   
High growth rate pigs had decreased lung lesion severity, but similar lymphoid lesions: 
Histopathologic lesions of tissues collected on 42 dpi were scored by a board certified 
pathologist blinded to the selection of pig groups.  The degree of interstitial pneumonia was 
scored between 0-4 based on microscopic evaluation of lung tissue from each lung lobe 
(Niederwerder et al. 2016a, Niederwerder, Bawa, Serao, et al. 2015).  Mean lung lesion scores 
were 2.3 and 1.2 for low and high growth rate groups, respectively (p = 0.05, Mann-Whitney U 
test; see Fig. 2A).  The majority of high growth rate pigs (80%) had normal lung or mild 
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multifocal interstitial pneumonia with <50% lung lobe involvement.  Representative pictures of 
microscopic lung lesions are shown in Fig. 2B-C.  These data show that even when pigs are 
lacking in the presentation of overt clinical signs of respiratory disease, significant interstitial 
pneumonia may still be present.     
Lymph nodes were examined for lymphocytic infiltration and for the presence of 
germinal centers as lymphoid depletion is essentially a pathognomonic lesion of PCVAD.  
Representative pictures of microscopic lymphoid lesions are shown in Fig. 2E-F.  Almost all pigs 
had some degree of lymphoid depletion, with only a single high growth rate pig having normal 
microscopic lymph node appearance (Fig. 2D).  Although mean scores were slightly increased 
for low growth rate pigs (1.9 compared to 1.6 for high growth rate pigs), no significant difference 
was detected between the two groups (p = 0.6, Mann-Whitney U test).     
The microbiomes of high growth rate pigs had increased diversity, Ruminococcaceae, and 
Streptococcaceae, but reduced Methanobacteriaceae: The presence of microbial families and 
species was determined by the Microbial Detection Array.  Overall, a total of 29 microbial 
families (Fig. 3A) and 112 microbial species (data not shown) were detected by the microarray.  
Microbial families included 6 viral families, 1 archaea family, and 22 eubacterial families.  Both 
DNA and RNA viruses were detected, including the families of Reoviridae, Picornaviridae, 
Astroviridae, Circoviridae, Parvoviridae, and Pospiviroidae (see Fig. 3A).  Bacterial families 
were detected from several phyla, including Firmicutes (10/22), Proteobacteria (6/11), 
Bacteroidetes (2/11), Actinobacteria (1/22), Tenericutes (1/22), Chlamydiae (1/22), and 
Spirochaetae (1/22).   
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Each of the 29 microbial families were detected at similar prevalence rates in both the 
high and low growth rate groups (Fig. 3A).  Both groups had a 100% prevalence rate of the 
bacterial families Lactobacillaceae, Lachnospiraceae, Prevotellaceae, and Mycoplasmataceae.  
In addition, the majority of pigs in both groups had the microbial families of Astroviridae, 
Methanobacteriaceae, Vibrionaceae, Veillonellaceae, Ruminococcaceae, and Streptococcaceae 
detected.  No significant difference was detected in the proportion of the two groups with each 
family detected (p > 0.05, Fisher’s exact test).  
 To further investigate microbiome differences between the two groups, the 
number of species detected within each family was compared (Fig. 3B).  The greatest number of 
species were detected in the Lactobacillaceae family, with a mean of 5.1 and 5.8 species detected 
in the low and high growth rate groups, respectively; however, this difference was not 
statistically significant (p = 0.44, Mann-Whitney U test).  Three families had notable differences 
in the number of species detected between the two groups.  First, there was a trend towards 
greater species diversity of the high growth rate pigs in the Streptococcaceae family; 4.2 species 
compared to 2.8 species detected in the low growth rate group (p = 0.0998, Mann-Whitney U 
test).  Overall, 12 Streptococcus species were detected in the feces of these pigs (Fig. 3C).  
Second, there was a significant decrease in the species diversity of the Methanobacteriaceae 
family in the high growth rate group.  An average of 1.4 Methanobacteriaceae species were 
detected in the high growth rate pigs versus an average of 2.5 species detected in the low growth 
rate pigs (p = 0.0086, Mann-Whitney U test).  Third, an increased number of Ruminococcaceae 
species were detected in the high growth rate group; 1.5 species versus 1.1 species in the low 
growth rate group (p = 0.0573, Mann-Whitney U test).  This data suggests that microbiome 
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composition at the time of virus exposure may play a role in determining outcome during co-
infection.  Most interestingly, species within the Streptococcaceae and Ruminococcaceae 
families may be beneficial to growth after co-infection whereas species within the 
Methanobacteriaceae family may be detrimental to growth after co-infection.  
 The prevalence rate of each of the 112 individual species were also compared 
between the two groups (data not shown).  Only a single species was detected at a significantly 
different rate between the high and low growth rate groups.  Streptococcus equi was detected at a 
significantly higher rate in high growth rate pigs (see Fig. 3C); 10 and 70% of the low and high 
growth rate pigs, respectively, had Strep. equi detected (p = 0.0198, Fisher’s exact test).  This 
data suggests that the presence of Streptococcus equi may be beneficial to weight gain during 
viral infection. 
Although we are unable to calculate the relative abundance of bacteria in the Firmicutes 
and Bacteroidetes phyla using the LLMDA, we were able to evaluate the overall number of 
species detected within each phylum and compare these numbers between the low and high 
growth rate groups (data not shown).  In general, the high growth rate pigs had increased 
numbers of Firmicutes species detected; 19.4 ± 1.4 species vs 15.8 ± 1.0 species for the low 
growth rate group (p = 0.08, Mann-Whitney U test).  High growing pigs also tended to have 
decreased species numbers detected in the Bacteroidetes phylum; 3.6 ± 0.3 species compared to 
4.1 ± 0.4 species in the low growing pigs (p = 0.34, Mann-Whitney U test).  Although the 
differences in the current study were not statistically significant, it is interesting to consider the 
similarities with characteristics of the obese human microbiome, where increased Firmicutes 
!23
bacteria coupled with reduced Bacteroidetes bacteria are associated with obesity (Ley et al. 
2006a).   
Microbiome diversity was determined by calculating the number of families and species 
detected in the feces of each pig (Fig. 4).  The mean number of families detected in the low 
growth rate group was 13.1 with a range of 9-16 compared to a mean of 15.1 with a range of 
10-18 for the high growth rate group.  The difference in family diversity between the two groups 
was significant (p = 0.0385, Mann-Whitney U test).  Species diversity between the two groups 
followed a similar trend.  The mean number of species detected in the low growth rate group was 
32.7 with a range of 29-37 whereas the high growth rate group had a mean of 36.9 species with a 
range of 29-42.  The difference in species diversity was also significant (p = 0.0328, Mann-
Whitney U test).  Overall, high growth rate pigs had greater microbiome diversity, on both a 
family and species level, than low growth rate pigs.  This data suggests that increased 
microbiome diversity may contribute to improved weight gain in pigs after co-infection.         
Discussion 
The current study builds on our previous work describing the microbiome profiles of best 
and worst clinical outcome pigs 10 weeks after co-infection with PRRSV and PCV2 
(Niederwerder et al., 2016).  The study described herein sought to investigate the microbiome 
characteristics prior to co-infection that may predict or predispose outcome.  Second, in the 
current study, we included only those pigs which had not developed clinical signs warranting 
veterinary intervention or antibiotic treatment. 
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Prior to profiling the microbiome, we also investigated several other pathogenic 
characteristics of PRRSV/PCV2 co-infection.  Perhaps the most interesting was the significant 
increase in virus replication of low growth rate pigs.  This was surprising given the subclinical 
nature of disease and again emphasizes the importance of pathogen load in determining even 
subclinical outcomes of viral infections.  Moreover, the low growth rate pigs had more severe 
lung lesions, with 2 low growth rate pigs having severe diffuse interstitial pneumonia.  This is 
important to consider in a population of infected pigs, as poor growth, even in the absence of 
dyspnea, coughing, or nasal discharge, may be indicative of severe pulmonary pathology.  
Furthermore, this underscores the significant impact of subclinical infections on animal health 
and welfare.   
At the level of the fecal microbiome, the LLMDA detected 29 microbial families and 112 
microbial species, including viruses, bacteria, and archaebacteria in samples from pigs.  In this 
study, we observed an increase in the Firmicutes:Bacteroidetes species ratio in the microbiomes 
of high growth rate pigs (5.6 compared to 4.2 for the low growth rate group; p = 0.05, Mann-
Whitney U test).  The association between the relative abundance of Firmicutes to Bacteroidetes 
can be found in studies of human obesity.  The microbiome of obese individuals has been 
described as having an enhanced ability to extract energy from food (Turnbaugh et al. 2006) and 
is typically characterized by an increase in the abundance of the Firmicutes phylum coupled with 
a decrease in the abundance of the Bacteroidetes phylum (Ley et al. 2006a).  Similar to humans, 
obese pigs have also been described as having decreased members of the Bacteroidetes phylum 
when compared to lean pigs (Guo et al. 2008) and have a positive correlation between weight 
gain and the Firmicutes phylum (Pedersen, Andersen, Molbak, et al. 2013).  We found similar 
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correlations in the current study between high and low growth rate pigs, supporting a role for 
Firmicutes and Bacteroidetes bacteria in growth during viral infection; however, limitations to 
quantifying the relative abundance of microbial populations with the LLMDA should be 
considered. 
Perhaps the most intriguing microbiome characteristic present in low growth rate pigs 
prior to infection was the decrease in microbiome diversity (see Fig. 4).  This finding was 
consistent with our previous work, where pigs with the worst clinical outcome had reduced 
microbiome diversity at 70 dpi compared to pigs with the best clinical outcome (Niederwerder et 
al. 2016a).  Reduced microbiome diversity is associated with the development of several non-
infectious diseases of the respiratory tract, such as allergy and asthma (Tulic, Piche, and 
Verhasselt 2016, Abrahamsson et al. 2014, Bisgaard et al. 2011), as well as the severity of 
infectious respiratory disease following experimental inoculation.  For example, 
Schachtschneider et al. (2013) evaluated the effects of increasing microbiome diversity through 
fecal microbiota transplantation on the response of pigs to Mycoplasma hyopneumoniae 
infection.  Pigs with increased microbiome diversity had a more rapid antibody response, 
decreased gross lung lesions, and a significant reduction in coughing compared to their non-
transplanted littermates (Schachtschneider et al. 2013).  Similar effects have been seen in mice 
models of human respiratory pathogens.  For example, Schuijt et al. (2016) compared antibiotic-
treated mice with reduced microbiome diversity to mice with endogenous microflora in response 
to Streptococcus pneumoniae infection.  Mice with increased microbiome diversity had reduced 
S. pneumoniae present in lung tissue, enhanced alveolar macrophage phagocytosis, lower 
mortality rates, and decreased interstitial pneumonia (Schuijt et al. 2016).  Taken together, 
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microbiome diversity appears to play an advantageous role in the host response to pathogens 
targeting pulmonary tissues.  Furthermore, microbiome diversity has proven to be beneficial in 
the response of pigs to 3 of the most important swine pathogens, PRRSV, PCV2 and M. 
hyopneumoniae.         
 In addition to microbial diversity, differences in microbiome composition were 
also detected between high and low growth rate pigs (Fig. 3B).  First, high growth rate pigs had 
increased species present in the Streptococcaceae family with a specific increase in the 
prevalence of the species Streptococcus equi (Fig. 3C).  Other studies investigating weight gain 
and the swine microbiome have also found associations with members of the Streptococcaceae 
family.  Kim et al. (2016) reported a positive correlation between the abundance of 
Streptococcaceae in feces and weight gain in growing pigs being fed the antibiotic growth 
promoter tylosin (Kim et al. 2016).  In 2013, Pedersen et al. compared microbiome 
characteristics between obese and lean pigs that were either cloned or not cloned.  Although 
Streptococcaceae was 6.3 fold higher in the terminal ileum of obese cloned pigs when compared 
to their lean counterparts, this finding was not consistent in samples collected from the colon.  In 
obese cloned and non-cloned pigs, the abundance of Streptococcaceae in the colon was 
decreased when compared to lean pigs (Pedersen, Andersen, Hermann-Bank, et al. 2013).  
Collectively, these results suggest that Streptococcus species may play a role in weight gain and 
the availability of nutrients in swine; however, this role may be dependent upon location in the 
gastrointestinal tract. 
 A second microbiome composition shift occurred within the Archaea family of 
Methanobacteriaceae.  These archaebacteria were the only microbes detected at an overall 
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higher prevalence rate in low growth rate pigs.  Species detected within the 
Methanobacteriaceae family included Methanobacterium sp., Methanobrevibacter ruminantium, 
and Methanobrevibacter smithii.  Similar to our findings, Luo et al. (2012) reported that lean 
pigs had a greater abundance and diversity of methanogens in feces when compared to obese 
pigs (Luo et al. 2012).  Interestingly, methanogens have also been associated with host 
metabolism and several weight phenotypes in humans (Barlow, Yu, and Mathur 2015); however, 
studies have been inconsistent in their findings (Zhang et al. 2009, Armougom et al. 2009, 
Million, Maraninchi, et al. 2012, Lee et al. 2011, Million et al. 2013, Schwiertz et al. 2010).  For 
example, Million et al. (2013) found that the prevalence of Methanobrevibacter smithii was 
negatively correlated with body mass index when comparing the feces of obese, overweight, 
lean, and anorexic individuals in France (Million et al. 2013).  In contrast, Lee et al. (2011) 
reported that the presence and abundance of methanogens was associated with higher body mass 
index and waist circumference in Korean women (Lee et al. 2011).  For cattle, sheep and goats, it 
is well known that methane production by methanogens in the rumen results in lost available 
energy from the diet (Hook, Wright, and McBride 2010, Johnson and Ward 1996).  In 
monogastrics, however, additional research into how methanobacteria impact nutrient 
availability and weight gain is needed to better define their role in host metabolism. 
 The final microbiome composition feature associated with improved growth was 
the presence of increased species in the Ruminococcaceae family.  Ruminococcaceae species are 
common gut inhabitants of both ruminants and monogastrics, considered beneficial due to a 
major role in cellulose digestion and the production of short-chain fatty acids.  The positive 
correlation between Ruminococcaceae species abundance and level of dietary fiber in swine has 
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long been established (Varel, Robinson, and Jung 1987, Varel 1987, Varel and Yen 1997).  
Recently, high relative abundance of the Ruminococcaceae family was associated with reduced 
fecal Salmonella shedding in pigs after infection with Salmonella enterica serovar Typhimurium 
(Bearson et al. 2013).  Other beneficial effects of Ruminococcaceae have been shown in 
chickens where improved feed conversion ratios were associated with increased caecal 
Ruminococcaceae abundance (Stanley et al. 2016) and in mice, where Ruminococcus gnavus was 
shown to reverse impaired growth phenotypes after transplanting the microbiota from 
malnourished children into germ-free mice (Blanton et al. 2016).  Due to their role in metabolism 
and overall gut health, increasing Ruminococcaceae species through inoculation or through fiber 
source may be a potential target for improving the growth of health-challenged pigs.       
 One finding from our initial study that was inconsistent with the current study was 
the increase in non-pathogenic Escherichia coli in the feces of pigs with improved clinical 
outcomes (Niederwerder et al. 2016a).  Several study design differences may account for this 
discrepancy.  Perhaps the most likely is timing of collection (i.e., PRRSV/PCV2 co-infection 
presumably shifts the microbial populations and collecting feces prior to or after viral infection 
would impact the microbiome).  Second, pigs in the worst clinical outcome group had been 
treated with antibiotics.  It is possible that antibiotic therapy targeted and reduced E. coli 
prevalence in pigs with poor outcomes.  Nonetheless, due to the potential role of Escherichia coli 
on weight (Looft et al. 2012, Schieber et al. 2015), further studies into the effects of E. coli on 
outcome after PRRSV/PCV2 co-infection are warranted.   
!29
3.  Microbiome trends after co-infection indicate that improved 
growth rates of pigs infected with porcine circovirus type 2 (PCV2) 
and porcine reproductive and respiratory syndrome virus 
(PRRSV) are determined by microbiome composition prior to 
challenge 
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Introduction 
In December 2016, the US swine herd showed the highest hog inventory since 1943, and 
the highest recorded breeding herd productivity in our history. The November 2016 USA swine 
exports were a record high at 510 million pounds and US pork exports are expected to increase 
to 5.44 billion pounds in 2017.  In the last 30 years, porcine reproductive and respiratory 
syndrome virus (PRRSV) and porcine circovirus type 2 (PCV2) have cost billions of dollars in 
production loss on a global scale. PRRSV is considered the most economically detrimental swine 
pathogen and has the most potential to impact the global swine industry (Chand, Trible, and 
Rowland 2012b). As a single-stranded RNA virus in the family Arteriviridae, PRRSV causes 
respiratory disease and negatively impacts weight gain in developing pigs (Benfield, Nelson, 
Collins, Harris, Goyal, Robison, Christianson, et al. 1992).  PCV2 is a single stranded DNA virus 
in the family Circoviridae that has the capacity to cause a variety of disease syndromes known as 
porcine circovirus associated diseases (PCVAD). PCVAD includes respiratory disease, enteric 
disease, skin and renal disease, as well as muscle wasting (Segalés 2012). Both PRRSV and 
PCV2 can present subclinically or result in systemic infections that can cause primary lung 
pathology, and modulate the immune response.  Type I interferon production is antagonized by 
PRRSV which suppresses innate immunity (Chen et al. 2010, Han and Yoo 2014) while PCV2 
causes lymphoid depletion in lymph tissues (Opriessnig and Langohr 2013).  Although these 
viral infections can have a profound impact alone, co-infection with both viruses enhance disease 
and can result in a wide range of overt clinical signs. Despite this, the majority of pigs co-
infected with PCV2 and PRRSV result in subclinical infections with overall morbidity being less 
than 30% (Niederwerder, Bawa, Serão, et al. 2015).  
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 The collection of microorganisms located within the gastrointestinal tract can be 
defined as the microbiome. These microorganisms play a critical role both in nutrient availability 
and immunity (Honda and Littman 2016, Turnbaugh et al. 2006), having been associated with 
outcome during systemic viral infections in both humans and mice models.  Microbiome 
associations have been found with viruses primarily affecting the respiratory tract, such as 
respiratory syncytial virus and influenza virus (Fujimura et al. 2014, Ichinohe et al. 2011), as 
well as viruses considered immunomodulatory, such as human immunodeficiency virus (Mudd 
and Brenchley 2016).  Disease progression, airway inflammation, immune response, and 
morbidity can all have associations with microbiome composition and diversity during these 
viral infections.  
The focal point of our study is to understand the role of the microbiome and its impact on 
the response to systemic infection in swine. To follow up on our previous study regarding the 
initial porcine microbiome and its impact on the outcome of PRRSV and PCV2 co-infection, we 
followed the same protocols to observe changes in microbiome during peak viremia (21 days 
post-infection) and viral clearance (42 days post-infection). Furthermore we compared changes 
in specific microbiome species between the initial microbiome we previously studied (0 days 
post-infection) with 21 dpi and 42 dpi to identify important trends. We continued to implement 
use of the Lawrence Livermore Microbial Detection Array (LLMDA), which was developed to 
detect all known microbes for which whole genome sequences are available.  Current as of June 
2013, this technology allows for the detection of 8,101 microbes and has been used in the 
detection of known and unknown microbes in porcine feces, serum, lung, oral fluids, lymph node 
suspension and tonsil (Niederwerder et al. 2016a, Jaing et al. 2015a).  
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In a recent study, we investigated the associations between the microbiome and clinical 
outcome in pigs following PRRSV/PCV2 co-infection (Niederwerder et al. 2016a).  Best and 
worst clinical outcome pigs were selected based on the presence and severity of clinical disease 
as well as weight gain after co-infection.  The fecal microbiomes of best clinical outcome pigs 
were characterized by increased diversity and increased prevalence of Escherichia coli 70 days 
after co-infection.  We followed this study up by investigating the microbiome characteristics 
that predispose outcome and the role of the microbiome in subclinical infections (Ober et al. 
2017). Though these studies confirm a potential role for the microbiome in outcome post 
PRRSV/PCV2 co-infection, it still remains unknown how the microbiome affects viremia, viral 
clearance, and differentiated growth rates.   
 In the current study, we followed up on our previous data by investigating the 
microbiome changes during peak viremia and after viral clearance that may impact high and low 
growth rates after co-infection with in subclinically affected pigs. We hypothesized that 
microbiome composition differences prior to co-infection with PCV2 and PRRSV would be 
maintained during the co-infection period; however these results did not remain significant. Our 
results demonstrate that microbiome composition on 0 dpi may play a larger role in the outcome 
of subclinical disease in pigs than microbiome composition during viremia or after viral 
clearance.  
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Materials and Methods 
Animals and Housing: At weaning, three week old barrows (n=50; average age 23.5 ± 2.6 days) 
were obtained from a PRRSV negative high health commercial herd. These piglets were not 
vaccinated for PCV2 and although these piglets were derived from a sow herd that was 
previously vaccinated with a PCV2 capsid subunit vaccine they were used without regard to 
maternal antibody. All pigs kept under BSL-2 condition at the Kansas State University Large 
Animal Research Center and were housed in a single environmentally controlled room. Groups 
of 8-10 piglets were randomly allocated into 13.4 m2 pens with ad libitum access to food and 
water. A 4-week acclimation period was allotted to all pigs prior to co-infection. This current 
study was conducted as a subcomponent of a larger project focused on assessing the role of host 
genetics in determining the outcome following co-infection with PRRSV and PCV2. All studies 
utilizing animals and viruses were done in accordance with the Federation of Animal Science 
Societies (FASS) Guide for the Care and Use of Agricultural Animals in Research and Teaching, 
the USDA Animal Welfare Act and Animal Welfare Regulations, and approved by the 
Institutional Animal Care and Use Committee as well as the Institutional Biosafety Committee at 
Kansas State University.  
Viruses: Both viral isolates of PRRSV and PCV2b used in this study were originally derived 
from the lymph node of a pig with severe postweaning multisystemic wasting syndrome 
(PMWS) as previously described (Trible and R.R. Rowland 2012)(16). The PCV2b isolate 
(GenBank accession no. JQ692110) was attained by preparing a lymph node suspension enriched 
from PCV2 as previously described (Niederwerder, Bawa, Serão, et al. 2015, Niederwerder et al. 
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2016b)(8,14). PRRSV (isolate KS62; GenBank accession no KM035803) was isolated by 
propagation on MARC-145 cells. It was then recombined with the PCV2 homogenate to infect 
cesarean-derived, colostrum deprived (CD/CD) pigs. A lymph node/lung combined homogenate 
was further prepared from the CD/CD pigs, and PRRSC and PCV2 were further isolated by the 
same methods described. The inoculum was analyzed yielding two positive viral results of 
Torque teno sus virus (TTSuV) and porcine endogenous retrovirus (PERVs) but was negative for 
other heat-stable agents(Jaing et al. 2015b). Both viruses were titrated as previously described 
(Ober et al. 2017).  
Experimental design and sample collection: All 50 pigs were infected with PRRSV and 
PCV2b at roughly 8 weeks of age (average age 54.5 ± 2.6 days). A 2mL dose was created by 
recombining both viruses and consisted of 103.6 TCID50 PCV2b and 105 TCID50 PRRSV in 
MEM. The pigs were inoculated by delivering 1mL intramuscularly and 1mL intranasally. Fecal 
samples were collected from all 50 pigs prior to co-infection. Body weights and blood samples of 
each pig were collected on 0, 7, 14, 21, 28, 35, and 42 days post infection (dpi). An additional 
blood sample was taken from each pig on 4 dpi. 20 pigs were selected on day 35 to represent 
high growth rate pigs (n=10) and low growth rate pigs (n=10) by calculating the average daily 
gain (ADG) between 0 and 35 dpi as the change in weight (kg) over the change in time. Further 
information regarding calculations and figures illustrating growth rate group selection can be 
found in our previous paper(Ober et al. 2017). All pigs were assessed daily by a veterinarian or a 
veterinary assistant for the presence of clinical signs that are associated with PRRSV/PCV2 co-
infection (dyspnea, coughing, nasal discharge, aural cyanosis, open mouth breathing, decreased 
!35
body condition, muscle wasting, lethargy, depression, joint effusion, lameness, and pallor or 
jaundice). Any pig that exhibited overt clinical disease requiring veterinary medical treatment 
was excluded from selection. This would include pigs needing treatment for dyspnea, mucoid 
rhinorrhea, lameness with joint effusions, pallor or jaundice with muscle wasting, or lethargy or 
depression with pyrexia. At 42 dpi the 20 selected pigs were humanely euthanized in accordance 
with the American Veterinary Medical Association Guidelines for the Euthanasia of Animals and 
complete necropsies were performed. For more information regarding the outcome of the 
necropsies, refer to our earlier publication (Ober et al. 2017). 
Microarray Analysis of Fecal Samples: The Lawrence Livermore Microbial Detection Array 
(LLMDA) was designed to detect all sequenced microbes and was developed at Lawrence 
Livermore National Laboratory. The LLMDA oligonucleotide probes are 60 nucleotides in 
length and designed to detect all sequenced microbial families with a large number of probes per 
sequence and to improve sensitivity in the evaluation of microbial nucleic acids in a variety of 
samples. For this study, the microbiome of the fecal samples were analyzed using version 7 of 
the LLMDA in the 4plex 180K probe format. This version of the array targets all vertebrate 
infecting microbes including 3,856 viruses, 3,855 bacteria, 254 archaebacteria, 100 fungi, and 36 
protozoa. This high-density array and statistical analysis method has previously been tested 
extensively in a multitude of studies used for microbial detection in clinical samples and 
environmental studies (Ober et al. 2017, Niederwerder et al. 2016b, Jaing et al. 2015b, 
Rosenstierne et al. 2014b, Gardner et al. 2010b)  
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DNA and RNA from fecal samples were extracted using the PowerViral™ Environmental 
RNA/DNA Isolation Kit (MO BIO, San Diego, CA) in accordance to the manufacturer’s 
instructions.  Each sample initially consisted 600 µl of PV1 added to 0.25 g of feces in a bead 
beating tube included in the PowerViral™ kit.  Samples were homogenized and lysed using the 
vortex adaptor for the MO BIO Vortex-Genie 2 for 10 minutes at maximum speed.  The 
manufacturer’s standard protocols were used to further purify the samples. 100 µl of RNase-Free 
water was used to elute all samples. The purified nucleic acids were quantified using the Life 
Technologies Qubit fluorimeter.  For each sample, 10 µl of the extracted DNA and RNA was 
amplified using the random amplification procedure as previously described (18).  The amplified 
cDNA and DNA was purified with the Qiaquick PCR purification columns (Qiagen) and 
quantified using the Qubit fluorometer.  Between 400-500 ng of amplified cDNA and DNA were 
fluorescently labeled using a one-coloring labeling kit (Roche NimbleGen, Madison, WI) 
following the manufacturer’s instructions. 
The Agilent Technologies Oligo aCGH/ChIP-on-Chip Hybridization kit (Santa Clara, 
CA) was used to prepare the comparative genomic hybridization (CGH) mix.  For each sample, 
10 µg of fluorescently labeled DNA was mixed with CGH mastermix, denatured at 95˚C for 3 
min, and incubated at 65˚C until the arrays were ready to load.  The LLMDA version 7 4x180K 
format microarray (Agilent Technologies Inc., Santa Clara, CA) was utilized for this experiment.  
After being loaded onto the array, each sample hybridized for 40 hr at 65˚C in a microarray 
rotator oven (Agilent Technologies Inc., Santa Clara, CA) set to a speed of 20. The standard 
manufacturer’s protocol was then used to wash the microarrays with aCGH/ChIP-on-chip Wash 
Buffer 1 and Oligo aCGH/ChIP-on-chip Wash Buffer 2 (Agilent Technologies Inc., Santa Clara, 
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CA).   The arrays were each washed in CGH Wash 1 for 5 min at room temperature, followed by 
CGH Wash 2 for 1 min at 37˚C.  Nitrogen gas was used to remove particulate matter from the 
surface of each array.  Using the MS200 microarray scanner (Roche NimbleGen, Madison, WI), 
all arrays were scanned at a resolution of 2 µM.  
Microarray data was generated from the microbe sequences at ≥99% threshold using the 
CLiMax method developed at Lawrence Livermore National Laboratory (Gardner et al. 2010b)
(17).  The log likelihood for each of the positive targets is estimated from the BLAST similarity 
scores of the array feature and target sequences, together with the feature sequence complexity 
and other covariates derived from BLAST results. 
Statistical Analysis: The statistical analyses were performed using GraphPad Prism 7.02 
software (La Jolla, CA).  Individual species and family comparisons between each growth rate 
group was assessed using Fischer’s exact test. The Mann-Whitney U test was utilized to compare 
Microbiome diversity and number of species within family and phylum between groups.  
Fisher’s exact test was used to compare proportions of each growth rate group with individual 
species at the three different time points.  
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Results 
All pigs were selected, PRRSV and PCV2 viremia was measured, and pathology assessed 
in accordance with our previous paper (Ober et al. 2017). Similar to our original paper, the 
presence of microbial families and species were detected by using the Lawrence Livermore 
Microbial Detection Array. Throughout the entire study a total of 34 microbial families and 140 
individual microbial species were detected. The results from day 0 were previously reported 
(Ober et al. 2017). On 21 dpi, there were 31 microbial families that were detected (Figure 11) 
and 113 individual microbial species detected. On 42 dpi there were 25 microbial families 
(Figure 11) that were detected and 86 individual microbial species detected. On days 21 and 42 
the families Mycoplasmataceae, Prevotellaceae, and Streptococcaceae were detected at 100% 
prevalence in both high growth and low growth rate pigs. The majority of pigs on 21 and 42 dpi, 
had the bacterial families Lachnospiraceae, Lactobacillaceae, Methanobacteriaceae, and 
Vibrionaceae detected in their feces. The families Planctomycetaceae, Polyangiaceae, 
Erysipelotrichaceae, and Coriobacteriaceae were only detected in pigs at 21 dpi while the 
family Bacillaceae was only detected on 42 dpi. There was not a significant difference detected 
in the proportion of high growth and low growth groups within each family detected both on 21 
dpi and 42 dpi.  
 We wanted to investigate the microbiome differences between the 2 growth 
groups on 21 dpi and 42 dpi in the same manner that we investigated 0 dpi microbiome 
differences. The number of species detected within each family was compared on 21 dpi and on 
42 dpi. Previously on 0 dpi, we had found that there was a trend towards a greater species 
diversity within the Streptococcaceae family in high growth rate pigs, a significant decrease in 
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the species diversity of the Methanobacteriaceae family in high growth rate pigs, and an 
increased number of Ruminococcaceae species in high growth rate pigs. Despite this previous 
data, there was no statistical significance when comparing these two growth groups (Figure 12) 
on either day in terms of species diversity differences. This new information, taken with our 
original findings suggests that the microbiome composition at the time of viral infection may 
play a larger role in determining the outcome during co-infection than microbiome composition 
during peak viremia or after viral clearance. There was no statistically significant individual 
species variation on either 21 or 42 dpi. Furthermore, we previously determined that the 
difference in family diversity between the two growth rates was statistically significant on 0 dpi 
and the species diversity between the two groups followed a similar trend. On 21 and 42 dpi 
there was no longer a statistically significant difference in family diversity or species diversity 
between the two groups (Figure 12), further supporting that 0 dpi microbiome composition may 
play a larger role in disease outcome than days after disease progression.  
The trends within individual species of bacteria and viruses were compared between the 
two growth groups. We looked at the presence of specific species on 0 dpi and compared the 
initial number of pigs that were positive for each species with the number of pigs that were 
positive for each species at the end of the study on 42 dpi. We then compared the initial number 
of pigs with a species on 0 dpi with pigs on 21 dpi and then with 21 dpi against 42 dpi. The 
seven bacterial families with specific species that had statistically significant increases or 
decreases in number over the experiment included Lactobacillaceae, Streptococcaceae, 
Lachnospiraceae, Mycoplasmataceae, Clostricaceae, Methanobacteriaceae, and 
!40
Spirochaetaceae. The viral family, Astroviridae, was the only viral family that had specific viral 
species experience a statistically significant decrease over the course of the experiment. 
 The family Lactobacillaceae had the most individual species that showed statistically 
significant trends during our experiment. The four species were Lactobacillus crispatus, 
Lactobacillus acidophilus, Lactobacillus sakei, and Lactobacillus amylovorous. For all 4 species, 
in both high growth and low growth groups there was a decrease in the number of positive pigs 
for each species on 0 dpi when compared with 42 dpi. From 0 to 21 dpi, the high growth rate 
group experienced a statistically significant decrease from 8 to 2 in pigs positive for 
Lactobacillus crispatus (p=0.0230, Fisher’s exact test). This number dropped again from 2 to 1 
when comparing 21 dpi with 42 dpi in the high growth rate group. The difference in the number 
of high growth rate pigs positive for Lactobacillus crispatus on 0 dpi compared with the number 
positive on 42 dpi was also significant, exhibiting an overall decrease from 8 to 1 (p=0.0198, 
Fisher’s exact test).  
There were 9 pigs in both the high growth rate and the low growth rate groups that were 
positive for Lactobacillus acidophilus on 0 dpi. For both high growth and low growth rate groups 
9 pigs were positive for Lactobacillus acidophilus on 0 dpi and for both groups 3 were positive 
on 42 dpi, each group experienced a significant decrease over the experiment (p=0.0198, Fisher’s 
exact test). Between 0 and 21 dpi each group experienced a statistically significant decrease with 
high growth rate pigs experiencing a decrease from 9 to 2 (p=0.0055, Fisher’s exact test) and low 
growth rate pigs decreasing from 9 to 3 (p=0.0198, Fisher’s exact test). Between 21 dpi and 42 
dpi the high growth rate group increased from 2 to 3 while the low growth rate group remained 
the same.  
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All 10 pigs in the high growth rate group were positive for Lactobacillus sakei on 0 dpi. 
This number decreased to 6 on 21 dpi (p=0.0867 decrease from day 0 to day 21, Fisher’s exact 
test) and to 5 on 42 dpi (p=>0.9999 decrease day 21 to day 42, Fisher’s exact test). The decrease 
that occurred between 0 and 42 dpi for the high growth rate group was significant (p=0.0325, 
Fisher’s exact test). The low growth rate groups initially had 7 pigs positive for Lactobacillus 
sakei which decreased to 3 on 21 dpi and then increased to 5 on 42 dpi, there were no significant 
changes for the low growth rate group.  
Both high growth and low growth groups each had 9 pigs positive for Lactobacillus 
amylovorous on 0 dpi. Both groups experienced a statistically significant drop to 3 pigs on 21 dpi 
(p=0.0198, Fisher’s exact test). Low growth rate pigs increased to 6 positive for Lactobacillus 
amylovorous on 42 dpi, which high growth rate pigs increased to 5 (p=0.3698 and p=0.6499 
respectively, Fisher’s exact test). Interestingly, in 3 out of 4 of the species in Lactobacillaceae 
that experienced a decrease in the number of pigs positive for that species, the statistically 
significant decrease occurred between initial infection (0 dpi) and peak viremia (21 dpi).  
Streptococcus equinus Streptococcus bovis and Streptococcus thermophilus were the two 
Streptococcaceae species that showed an important difference between the three different time 
points. Streptococcus equinus Streptococcus bovis was initially found in 8 pigs in the high 
growth rate group and 6 pigs in the low growth rate group, by 42 dpi, both growth rate groups 
were reduced to 0. The decrease from 0 to 42 dpi in both groups was significant with a p-value of 
0.0007 for the high growth rate group, and a p-value of 0.0108 for the low growth rate group. On 
day 21 the high growth rate group decreased from 8 to 5 (p=0.3034, Fisher’s exact test), while 
the low growth rate group decreased from 6 to 3 (p=0.3698, Fisher’s exact test).  From 21 dpi to 
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42 dpi, high growth pigs positive for Streptococcus equinus Streptococcus bovis significantly 
decreased from 5 to 0 (p=0.0325, Fisher’s exact test) and low growth rate pigs decreased from 3 
to 0 (p=0.2105, Fisher’s exact test). Streptococcus thermophilus also showed significant decrease 
in both growth groups between 0 dpi and 42 dpi. There were initially 9 high growth pigs and 7 
low growth pigs with Streptococcus thermophilus in their microbiome which were both reduced 
to 1(p=0.0030 high growth; p=0.0198 low growth, Fisher’s exact test). The high growth 
decreased in numbers positive for Streptococcus thermophilus to 6 on 21 dpi and to 1 on 42 dpi. 
The low growth rate pigs decreased to 3 positive pigs on 21 dpi and to 1 on 42 dpi. There were 
no further significant findings.  
There was a single bacterial species, Dorea longicatena, in the family Lachnospiraceae 
that had significant data changes during our experiment. The high growth rate group initially had 
7 positive pigs on 0 dpi which decreased to 1 by 42 dpi (p=0.0198, Fisher’s exact test). Between 
0 dpi and 21 dpi the number of high growth rate pigs with Dorea longicatena, remained the same 
at 7. For the high growth rate pigs the significant decrease from 7 to 1 occurred between 21 dpi 
and 42 dpi (p=0.0198, Fisher’s exact test). When observing changes for the low growth rate 
group, there were no significant changes in the number of pigs positive for Dorea longicatena 
during our experiment (4 on 0 dpi, 3 on 21 dpi, and 1 on 42 dpi; 0 to 21 dpi, p=>0.9999; 21 to 42 
dpi, p=0.5820; 0 to 42 dpi, p=0.3034, Fisher’s exact test).  
Of the Mycoplasmatacea family, Mycoplasma arthritidis and Mycoplasma 
hyopneumonia both showed significant changes between time points during this study. There was 
1 pig in the high growth rate group that had Mycoplasma arthritidis on 0 dpi, this increased to 5 
pigs on 21 dpi, and then to 7 pigs on 42 dpi. Although the increase between 0 dpi and 21 dpi and 
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21 and 42 dpi were not significant (p=0.1409 and p=0.6499 respectively, Fisher’s exact test), the 
overall increase between 0 and 42 dpi was significant (p=0.0198, Fisher’s exact test). The low 
growth rate group also have 1 pig with Mycoplasma arthriditis on 0 dpi which increased to 7 
pigs on 21 dpi, and remained at 7 pigs on 42 dpi. The increase in the number of low growth pigs 
with Mycoplasma arthriditis between 0 dpi and 21 dpi as well as the overall increase when 
comparing 0 dpi with 42 dpi were both significant (p=0.0198 for both, Fisher’s exact test). There 
was no significant data regarding the changes in Mycoplasma hyopneumoniae for the high 
growth group (8 pigs on 0 dpi, 4 pigs on 21 dpi, and 7 pigs on 42 dpi). The low growth rate 
group initially had 10 pigs with Mycoplasma hyopneumoniae on 0 dpi which significantly 
decreased to 5 pigs on 21 dpi, followed by a slight increase to 6 pigs on 42 dpi. Between 0 dpi 
and 21 dpi this decrease was significant (p=0.0325, Fisher’s exact test).  
Clostridium sartagoforme and Clostridium botulinum both increased in the number of 
pigs with each species during our experiment for both growth groups. Clostridium sartagoforme 
increased from 0 pigs positive on 0 dpi in the high growth rate group to 4 pigs on 21 dpi and then 
5 pigs on 42 dpi. The incremental increases from 0 dpi to 21 dpi and then from 21 to 42 dpi were 
not significant however, the overall increase from 0 to 42 dpi was significant (p=0.0325, Fisher’s 
exact test). Although there was a steady increase in Clostridium sartagoforme in the low growth 
rate group there were not statistically significant changes. Conversely, in regards to Clostridium 
botulinum, there were no significant increases in the high growth rate pigs, yet in the low growth 
rate group there was a significant increase between 0 and 21 dpi. In the low growth rate group 
there were initially 2 pigs positive for Clostridium botulinum on 0 dpi which significantly 
increased to 8 positive pigs on 21 dpi (p=0.023, Fisher’s exact test). Between 21 dpi and 42 dpi 
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this number decreased to 7 (p=>0.9999, Fisher’s exact test), the overall change from 2 pigs on 0 
dpi to 7 pigs on 42 dpi was also not statistically significant.  
Of the Methanobacteriaceae family, Methanobrevibacter ruminantium showed an overall 
significant increase in the high growth rate group from 2 pigs on day 0 to 9 pigs on 42 dpi 
(p=0.0055). Although this species of bacteria steadily increased in the number of pigs to 4 pigs at 
21 dpi and to 9 pigs at 42 dpi, these incremental increases were not significant (p=0.06285 and 
p=0.0573 respectively, Fisher’s exact test). There were no statistically significant changes noted 
for Methanobrevibacter ruminantium in the low growth rate group. The other species was 
Methanobacterium sp SWAN which showed a statistically significant decrease between 21 dpi 
and 42 dpi in the high growth rate group. On 0 dpi the high growth rate group initially had 5 pigs 
positive for Methanobacterium sp SWAN, this number of pigs was increased to 8 on 21 dpi 
(p=0.3498 from 0 to 21 dpi, Fisher’s exact test), and then significantly decreased from 8 pigs on 
day 21 to 1 pig on day 42 (p=0.0050, Fisher’s exact test). The overall decrease from 5 to 1 was 
not significant (p=0.1409, Fisher’s exact test).  The low growth rate group of pigs did not yield 
any statistically significant differences in pigs positive for Methanobacterium sp SWAN.  
There were 2 bacterial species that showed significance in the family Spirochaetaceae. 
The first was Treponema succinifaciens, which in the low growth rate group significantly 
increased in the number of pigs with this species from 0 to 8 between 0 and 21 dpi (p=0.0007, 
Fisher’s exact test). The number of low growth rate pigs then decreased to 7 on 42 dpi. The 
decrease between 21 dpi and 42 dpi was insignificant but the overall increase in the number of 
low growth pigs with Treponema succinifaciens on 0 dpi when compared to 42 dpi was 
significant (p=0.0031, Fisher’s exact test). There were no significant findings in the changes to 
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the number of pigs with Treponema succinifaciens in the high growth rate group. The other 
species, Treponema brennaborense, showed a similar statistically significant increase in the 
number of pigs with this species between 0 and 21 dpi in the low growth rate group. On 0 dpi, 1 
pig in the low growth rate group was positive for Treponema brennaborense which increased to 7 
pigs on 21 dpi (p=0.0198, Fisher’s exact test). This number then decreased to 5 pigs on 42 dpi. 
Neither the overall increase from 1 on 0 dpi to 5 on 42 dpi, nor the decrease from 7 on 21 dpi to 
5 on 42 dpi were significant (p=0.1409 and p=0.6499 respectively, Fisher’s exact test). There 
were no significant findings for Treponema brennaborense in the high growth rate pigs. 
Interestingly, there were significant increases within the number of pigs in the low growth groups 
for both species that occurred between 0 dpi and 21 dpi which the high growth rate groups did 
not yield significant data for the Spirochaetaceae family.  
Overall, there were five viral families detected in all pigs over the course of the 
experiment (Astroviridae, Circoviridae, Reoviridae, Pircornaviridae, and Parvoviridae). Of 
these, two species from the family Astroviridae, were the only viral species that experienced a 
statistically significant change during the experiment. There was an overall decrease in the 
proportion of pigs positive for Astrovirus wild boar in both the high growth rate pigs and the low 
growth rate pigs. 9 pigs in both groups tested positive for Astrovirus wild boar on 0 dpi. On 42 
dpi, 4 pigs in the high growth rate group and 5 pigs in the low growth rate group tested positive 
for Astrovirus wild boar (p=0.0573 and 0.1409 respectively; Fisher’s exact test). Between 0 dpi 
and 21 dpi the high growth rate group experienced statistically significant decrease in the number 
of pigs positive for Astrovirus wild boar, decreasing from 9 to 3 (p=0.0198, Fisher’s exact test). 
Between 21 and 42 dpi there was an increase from 3 to 4 in pigs testing positive for Astrovirus 
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wild boar (p=>0.9999, Fisher’s exact test). The low growth experienced insignificant decreases 
from 9 to 8 and from 8 to 5 between 0 and 21 dpi and 21 and 42 dpi respectively (p=>0.9999 and 
p=0.3498, Fisher’s exact test). The other viral species, Porcine Astrovirus, also experienced an 
overall decrease in positive pigs in both the high growth group and the low growth group. There 
were 9 high growth rate pigs that initially were positive for Porcine Astrovirus which decreased 
to 5 on 21 dpi and then to 3 on 42 dpi. The overall decrease between 0 and 42 dpi was 
statistically significant (p=0.0198, Fisher’s exact test). The low growth rate group also had 9 pigs 
initially positive for Porcine Astrovirus on 0 dpi which decreased to 7 on 21 dpi, and then to 5 on 
42 dpi (p=0.582 from 0 to 21 dpi, p=0.6499 from 21 to 42 dpi, p=0.1409 from 0 to 42 dpi).  
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Discussion 
This current study is an extension of our previous study focusing on determining if the 
fecal microbiome characteristics present at the time of viral exposure were associated with 
outcome in subclincally affected pigs after co-infection with PRRSV and PCV2. We had 
previously determined that initial microbiome characteristics of high growth rate pigs included 
decreased Methanobacteriaceae, increased Streptococcaceae, and increased Ruminococcaceae 
as well as overall increased diversity (Ober et al. 2017). For this study we sought to observe the 
microbiome diversity between the high growth rate and low growth rate groups during peak 
viremia on 21 dpi and at viral clearance 42 dpi. Additionally, we pursued identification of 
significant trends of individual microbial species, comparing 0, 21, and 42 dpi, within both 
growth groups.  
We previously reported that high growth rate pigs had an increased species diversity at 0 
dpi (Ober et al. 2017). There were not statistically significant difference in microbial diversity 
between high growth rate and low growth rate groups on 21 dpi and 42 dpi. Our findings suggest 
that initial microbiome colonization may be an important factor in determining the outcome of 
disease. Decreased microbial species diversity has been associated with inflammatory bowel 
disease, asthma, and Clostridial difficile colitis in humans (Ott et al. 2004, Thavagnanam et al. 
2008, Chang et al. 2008). Furthermore it has been found in humans that the initial diverse 
microbiome composition can improve overall immune health such as increases secretory 
immunoglobulins such as IgA (Sjögren et al. 2009).  
 Lactobacillaceae are a non-pathogenic group of bacteria found in the intestines of 
humans and animals that produce lactic acid as a result of carbohydrate fermentation and have 
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also been found to present colonization of detrimental enteric pathogens through ability to adhere 
to the intestinal lining (Huang et al. 2004, Lee et al. 2012) as well as stimulating promotion of a 
healthy gastrointestinal microbiome (Walter et al. 2008). Although four species of 
Lactobacillaceae showed a significant decrease over our study, Lactobacillus amylovorus and 
Lactobacillus acidophilus may have the most impact. When compared with untreated piglets 
challenged with enterotoxegenic Escherichia coli (ETEC), piglets fed Lactobacillus sobrius—a 
phenotypically similar bacteria to Lactobacillus amylovorous—exhibited reduced levels of 
ETEC in their ileum and additionally had an improved daily weight gain (Konstantinov et al. 
2008). Million et al performed a meta-analysis on the effect of Lactobacillus species on weight 
gain in humans and animals and found that Lactobacillus acidophilus administration results in 
significant weight gain (Million, Angelakis, et al. 2012). In pigs, weaning piglets supplemented 
with Lactobacillus acidophilus in combination with other lactic acid producing bacteria showed 
improved feed conversion, feed intake, and weight gain (Giang et al. 2010). The significant 
decrease in the presence of this bacteria during viral co-infection with PCV2/PRRSV may have 
negatively impacted both groups. Possible supplementation with selected Lactobacillus species 
during infection may improve outcome in pigs affected with PCV2/PRRSV co-infections.  
We had previously determined that high growth rate pigs had an increased number of 
species present in Streptococcaceae family and also an increased prevalence in the specific 
species Streptococcus equi on 0 dpi. We did not find significant data when comparing the 
number of individual species in the Streptococcaceae family between high growth or low growth 
groups on 21 or 42 dpi, nor when comparing overall number of species. However, when we 
addressed the trends in the numbers of individual species, both high and low growth rate groups 
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showed a significant decrease in numbers for Streptococcus equinus Streptococcus bovis and 
Streptococcus thermophilus from 0 dpi to 42 dpi. The Streptococcus equinus/Streptococcus bovis 
complex are commensal and opportunistic pathogens of the GI tract previously found in pigs, 
ruminants, humans, and horses (Jans et al. 2015). In humans, Streptococcus bovis bacteremia is 
associated both with endocarditis as well as colon cancer (Ferrari et al. 2008).  In 2005, Bin-Nun 
et al found that prebiotic supplementation, including Streptococcus thermophilus, in low-birth 
weight human neonates decreased both the incidence and severity of necrotizing enterocolitis 
(Bin-Nun et al. 2005). Pre-treatment with Streptococcus thermophilus in rats subjected to 5-
Fluorouracil, significantly reduced histopathogy associated with chemotherapy induced intestinal 
mucositis (Whitford et al. 2009). Additionally, in a study comparing the growth of children 
supplemented with Bifidobacterium Bb12 with or without Streptococcus thermophilus against 
unsupplemented children, those that received probiotic supplementation with Streptococcus 
thermophilus showed improved growth over the other groups (Nopchinda et al. 2002). Our study 
shows that co-infection with PRRSV/PCV2 may be detrimental to the growth of both beneficial 
and harmful Streptococcal species. Further research into supplementation of Streptococcus 
thermophilus during disease in pigs are warranted to view potential benefits of weight gain.   
Of the Lachnospiraceae family, Dorea longicatena was the only species that showed a 
significant change during the experiment. High growth rate pigs experienced a significant 
decrease between 21 dpi and 42 dpi. In a 2015 study in post-menopausal women it was found 
that Dorea longicatena was negatively correlated with insulin resistance (Brahe et al. 2015) but 
this was the only relevant paper that we found during our literature search regarding Dorea 
longicatena and weight gain.  
!50
Mycoplasma arthritidis showed significant increases in both low and high growth rate 
groups over the course of the study, and specifically increased between 0 dpi and 21 dpi in the 
low growth rate group. Mycoplasma arthritidis is not known to cause disease in pigs, rather it 
causes rheumatoid polyarthritis in mice and rats (Kirchhoff et al. 1989). Interestingly our study 
does not reflect the results of there have been previous studies reporting that Mycoplasma 
hyopneumoniae potentiating the outcome of PRRSV. Thacker et al reported that pigs exposed to 
Mycoplasma hyopneumoniae 21 days prior to inoculation with PRRSV exhibited far more severe 
outcomes of PRRSV infection (Thacker et al. 2000). We saw a significant decrease in the 
presence of Mycoplasma hyopneumoniae in the low growth rate group between 0 dpi and 21 dpi.  
Of the Clostridiaceae family, we saw a significant increase in Clostridium sartagoforme 
from 0 dpi to 42 dpi in the high growth rate group while we saw a significant increase in 
Clostridium botulinum between 0 dpi and 21 dpi in low growth rate pigs. Clostridium 
sartagoforme is an anaerobic bacteria that possesses genomes that aid in the digestions of 
cellulose and chitin and produce volatile fatty acids (Nathani et al. 2016). Although there are no 
specific literature references to the impact of Clostridium sartagoforme on growth rate, it may be 
hypothesized that an increase in the presence of this bacteria may allow for more efficient 
digestion of plant materials and an increase in abundance of nutrients that lead to higher growth 
rates.  Clostridium botulinum can be detected at a high prevalence in many animal species feces 
and spores are ubiquitous in the environment. Clostridium botulinum has previously been 
isolated and identified from the swine intestine (Myllykoski et al. 2006) but has been described 
as a weak competitor against other bacterial species in the microbiome (Kautter et al. 1966). The 
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decrease in other bacterial species is likely the cause of Clostridium botulinum’s increase in the 
low growth pigs.  
We previously reported that on 0 dpi the low growth rate group of pigs had a higher 
prevalence rate of Methanobacteriaceae species than the high growth pigs. Yet during our 
follow-up study, Methanobrevibacter ruminatium had a significant increase in prevalence of this 
species in high growth rate pigs between 0 and 42 dpi while Methanbacterium sp SWAN had a 
significant decrease in the prevalence of this species in high growth rate pigs between day 21 and 
42 dpi. In ruminants, contrary to our findings, it has been suggested that Methanobrevibacter 
ruminantium can cause a 6% loss of ingested energy (Leahy et al. 2010). Methanobacterium sp. 
SWAN is equivalent to Methanobacterium paludis (Cadillo-Quiroz et al. 2014).  A literature 
search of both these species names yielded no results regarding the impact of these specific 
species on animal weight loss or gain. Further research into these species is indicated to provide 
a better understanding of relationship between these bacteria and outcome.  
The low growth rate group experienced a significant increase in two spirochetes during 
our study. Both Treponema succinifaciens and Treponema brennaborense significantly increased 
between 0 dpi and 21 dpi, with Treponema succinifaciens experiencing an overall significant 
increase from 0 dpi to 42 dpi. Treponema succinifaciens is a non-pathogenic spirochete that is 
often isolated from the swine colon (Cwyk and Canale-Parola 1979). Although Treponema 
brennaborense was once thought to be the causative agent of bovine digital dermatitis (Schrank 
et al. 1999), further studies have found Treponema brennaborense to be minimally pathogenic 
(Brandt et al. 2011). Although neither Spirochateaceae species are pathogenic, there may be a 
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negative correlation between the prevalence of these species in pigs and the outcome of 
subclinical PRRSV/PCV2 infections.  
Species in the family of virus known as Astroviridiae are non-enveloped RNA viruses 
that generally cause gastrointestinal disease in many species of mammals. In our study the high 
growth rate group experienced a significant decrease in the number of pigs with Astrovirus wild 
boar between 0 and 21 dpi and a significant decrease in Porcine astrovirus between 0 and 42 dpi 
while there was no significant change for either virus in the low growth rate group. A study in 
broiler chickens with Runting-stunting syndrome, a multifactorial syndrome that inhibits the 
growth of young birds, found that Astroviridae was one of the most abundant viral families 
found in the virome of affected birds (Devaney et al. 2016). In turkey poults, co-infection with 
turkey astrovirus type-2, turkey rotavirus, and Turkey reovirus has been shown to cause a 
decrease in weight gain (Spackman, Day, and Pantin-Jackwood 2010). There is a fair amount of 
literature characterizing astroviruses in pigs but not describing any correlations between 
astroviruses and weight loss or gain, further research is needed to explore the impact astroviruses 
have on the outcome of disease in swine.  
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4. Conclusion 
The first objective of these experiments was to first determine what microbiome 
characteristics predispose outcome in pigs with subclinical infections involving PRRSV and 
PCV2 and then to determine what role the microbiome plays in these subclinical infections. The 
conclusion drawn from the information collected from exploring the first objective was as 
follows: Infection with PRRSV and/or PCV2 results in significant production losses to the swine 
industry.  In this study, both microbiome diversity and composition were associated with 
response to co-infection with PRRSV and PCV2, including lung pathology, virus replication, and 
growth rate.  Microbiome characteristics of high growth rate pigs included increased diversity, 
decreased Methanobacteriaceae, increased Streptococcaceae, and increased Ruminococcaceae.  
Modulating the piglet microbiome to have one or more of these characteristics may be an 
alternative tool for control of disease associated with PRRSV and PCV2 
The second experimental objective was to determine if these changes in the microbiome 
were consistent during the post-infection period. From the results gathered while exploring the 
second objective, we concluded that individual or co-infections with PRRSV and PCV2 results 
detrimental production losses in the pork industry on a worldwide level. In this study no 
significance in microbiome diversity during peak viremia or after viral clearance were noted. 
Furthermore, these results support our hypothesis that modulating the piglet microbiome at 
weaning as opposed to during disease or after disease may have a positive impact on outcome. 
Supplementing pigs with select bacterial species that are reduced in the microbiome during 
infection during swine post-weaning periods may improve outcome during or after disease 
associated with PRRSV and PCV2.  
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Figure 1. Average daily gain (ADG) distribution between 0 and 35 days post-infection 
5. Figures and Tables 
 
Table 1. Total PRRSV and PCV2 virus replication between 0-42 dpi reported as area 
under the viremia curve (AUC) 
PRRSV PCV2
Low Growth Pigs High Growth Pigs Low Growth Pigs  High Growth Pigs
83.3 56.0 0.0 0.0
92.3 69.9 28.4 12.2
93.9 73.1 44.5 17.6
95.3 76.5 50.2 33.0
99.1 79.6 56.8 35.7
99.3 83.3 63.3 37.9
100.7 84.2 74.4 39.4
103.2 85.9 77.7 42.4
103.9 87.1 86.0 60.5
115.6 87.7 94.9 77.5
*Mean = 98.6 *Mean = 78.3 ‡Mean = 57.6 ‡Mean = 35.6
      SD = 8.5       SD = 9.9       SD = 28.5       SD = 22.6
*Significant difference between PRRSV means, p = 0.0001, unpaired t-test. ‡Trend 
towards greater total PCV2 replication in low growth pigs, p = 0.07, unpaired t-test. 
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Figure 2. Weight gain in pigs with high and low growth rates after co-infection with 
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Figure 5. PRRSV viremia of high and low growth rate pigs.  Data is shown as the mean ± 
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Figure 6. PCV2 viremia of high and low growth rate pigs.  Data is shown as the mean ± standard 
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Figure 7. Microbiome family composition in pigs with high and low growth rates 
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Figure 8. Number of species detected within each microbial family.  Data is shown as 
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Figure 9. Species composition of the Streptococcaceae family in pigs with high and low 
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Figure 11. 21 and 41 dpi microbiome composition of pigs with high and low growth rates 
after co-infection with PRRSV and PCV2. A. Microbiome family composition on day 21 is 
shown as the percent of low growth pigs (n=10) and high growth pigs (n=10) with each detected 
family on the array. B. Microbiome composition on 42 dpi is shown in the same manner as 21 
dpi. There was not a significant difference detected in the proportion of high growth and low 
growth groups within each family detected both on day 21 and day 42 (Fisher’s exact test, 
P>0.05). 
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Figure 12. Microbiome diversity in pigs with high and low growth rates after co-infection 
with PRRSV and PCV2 21 dpi and 42 dpi. The total number of microbial families if seen in A 
and microbial species is seen in B. Group means and standard deviations are shown via 
horizontal lines. On day 21 and day 42 there was not a statistically significant difference in 
family diversity or species diversity between the two groups. 
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Table 2. Trends in specific bacterial species from 0 dpi to 42 dpi. 
* Statistically significant date obtained through Fisher’s Exact test.  
Table 3. Trends in specific bacterial species from 0 dpi to 21dpi 
Species Growth 
Rate
0-42 DPI
0 dpi 42 dpi p-value
Lactobacillus crispatus High 8 1 0.0055*
Low 5 1 0.1409
Lactobacillus acidophilus High 9 3 0.0198*
Low 9 3 0.0198*
Lactobacillus sakei High 10 5 0.0325*
Low 7 5 0.6499
Streptococcus equinus Streptococcus 
bovis
High 8 0 0.0007*
Low 6 0 0.0198*
Streptococcus thermophilus High 9 1 0.003*
Low 7 1 0.0198*
Dorea longicatena High 7 1 0.0198*
Low 4 1 0.3034
Mycoplasma arthritidis High 1 7 0.0198*
Low 1 7 0.0198*
Clostridium sartagoforme High 0 5 0.0325*
Low 1 5 0.1409
Methanobrevibacter ruminatium High 2 9 0.0055*
Low 6 9 0.3034
Treponema succinifaciens High 2 6 0.1698
Low 0 7 0.0031*
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Species Growth 
Rate
0-21 DPI
0 dpi 21 dpi p-value
Lactobacillus crispatus High 8 2 0.023*
Low 5 2 0.3498
Lactobacillus acidophilus High 9 2 0.0055*
Low 9 3 0.0198*
Lactobacillus amylovorus High 9 3 0.0198*
Low 9 3 0.0198*
Mycoplasma arthriditis High 1 5 0.1409
Low 1 7 0.0198*
Mycoplasma hyopneumoniae High 8 4 0.1698
Low 10 5 0.0325*
Clostridium botulinum High 3 4 >0.9999
Low 2 8 0.023*
Treponema succinifaciens High 2 2 >0.9999
Low 0 8 0.0007*
Treponema brennaboense High 0 5 0.6285
Low 1 5 0.0198*
* Statistically significant date obtained through Fisher’s 
Exact test.
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Table 4. Trends in specific bacterial species from 21 dpi to 42dpi 
Table 5. Trends in specific viral species from 0 dpi to 42dpi 
Table 6. Trends in specific viral species from 0 dpi to 21 dpi 
Species Growth 
Rate
21-42 DPI
21 dpi 42 dpi p-value
Streptococcus equinus Streptococcus bovis High 5 0 0.0325*
Low 3 0 0.2105
Dorea longicatena High 7 1 0.0198*
Low 3 1 0.582
Methanobacterium sp SWAN High 8 1 0.0055*
Low 5 5 >0.9999
* Statistically significant date obtained through Fisher’s 
Exact test.
Species Growth 
Rate
0-42 DPI
0 dpi 42 dpi p-value
Porcine Astrovirus High 9 3 0.0198*
Low 9 5 0.01409
* Statistically significant date obtained through Fisher’s 
Exact test.
Species Growth 
Rate
0-42 DPI
0 dpi 21 dpi p-value
Astrovirus wild boar High 9 3 0.0198*
Low 9 8 >0.9999
* Statistically significant date obtained through Fisher’s 
Exact test.
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